SUBSCRIBE
SUBSCRIBE
News   FDA

US Approves Pfizer Inc. Generic of Novartis AG Genotropin

September 3, 2008 | 
1 min read
ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG's Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc's human growth hormone Genotropin.
FDA Approvals Europe
Pfizer Novartis
MORE ON THIS TOPIC
Capitol Hill COVID-19 blood testing, abstract virus testing during pandemic concept, State Building Washington DC, USA, 3d illustration
FDA
Opinion: Balancing Safety Access in Rare Disease—Lessons From Sarepta
February 25, 2026
 · 
6 min read
 · 
Joshua R. Mansbach
Pictured: Roche tower in Basel, Switzerland
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
 · 
1 min read
 · 
Nick Paul Taylor
screenshot of Marty Makary speaking on the Megyn Kelly Show
Vaccines
FDA’s Makary Backs mRNA Vaccines but Says Companies ‘Can Fund Their Own Research’
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor